scispace - formally typeset
C

Cristina Tassorelli

Researcher at University of Pavia

Publications -  406
Citations -  19055

Cristina Tassorelli is an academic researcher from University of Pavia. The author has contributed to research in topics: Migraine & Medicine. The author has an hindex of 50, co-authored 346 publications receiving 15732 citations. Previous affiliations of Cristina Tassorelli include University of Rochester Medical Center & UniFi.

Papers
More filters
Journal ArticleDOI

Cognitive Telerehabilitation for Older Adults With Neurodegenerative Diseases in the COVID-19 Era: A Perspective Study

TL;DR: In this paper, the authors implemented HomeCoRe (i.e., Home Cognitive Rehabilitation software) in order to offer an innovative approach and a valid support for home-based cognitive rehabilitation in neurodegenerative diseases, such as mild cognitive impairment and early dementia.
Journal ArticleDOI

Development and validation of the EUROLIGHT questionnaire to evaluate the burden of primary headache disorders in Europe

TL;DR: A 103-item self-reporting questionnaire to assess the burden of primary headache disorders on those affected by them, including headache characteristics, associated disability, co-morbidities, disease-management and quality of life, is developed and validated in five languages.
Journal ArticleDOI

Identification of distinct cellular pools of interleukin-1β during the evolution of the neuroinflammatory response induced by transient middle cerebral artery occlusion in the brain of rat

TL;DR: The regional and cellular expression of IL-1beta after ischemia-reperfusion injury in the brain of rat is investigated, and correlated cytokine expression with the activation/recruitment of glial cells in the damaged tissue.
Book ChapterDOI

Chapter 28 Identification of Novel Pharmacological Targets to Minimize Excitotoxic Retinal Damage

TL;DR: Original neurochemical and pharmacological evidence is discussed here to strengthen the role for excitotoxicity in RGCs death occurring in experimental, angle closure, glaucoma in conjunction with the discovery of novel molecular targets to potentiate endogenous prosurvival defenses in the glau comatous retina.